TREATMENT OF CNS METASTASES IN GERM-CELL TUMORS

被引:0
作者
CLEMM, C
GERL, A
WENDT, TG
POLLINGER, B
WINKLER, PA
WILMANNS, W
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,NEUROCHIRURG KLIN,W-8000 MUNICH 70,GERMANY
[2] UNIV MUNICH,KLINIKUM GROSSHADERN,RADIOL KLIN,W-8000 MUNICH 70,GERMANY
[3] UNIV MUNICH,KLINIKUM GROSSHADERN,TUMORZENTRUM MUNCHEN,BAD TRISSLIM KLINIK BAD TRISSLIM,W-8000 MUNICH 70,GERMANY
[4] UNIV MUNICH,KLINIKUM GROSSHADERN,MED 3 KLIN,W-8000 MUNICH 70,GERMANY
来源
UROLOGE-AUSGABE A | 1993年 / 32卷 / 03期
关键词
GERM CELL TUMOR; CNS METASTASES; RADIOTHERAPY; OPERATION; CHEMOTHERAPY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The incidence of CNS metastases in germ cell tumors is 2-5% and in very advanced disease over 20%. We report on 37 patients in whom CNS metastases were diagnosed with the CAT scanner. Twenty-nine patients were subsequently treated. In 19 cases, treatment consisted of radiotherapy, 1 patient was only operated on, and in 9 cases patients received combined surgery and radiotherapy. Two patients had seminomatous germ cell tumors, 27 patients non-seminomatous tumors. HCG levels were high in 11 cases. In31 patients the disease was in the advanced stages; in 6 the disease was at the early stage. If there was just a solitary tumor, operation was the preferred mode of treatment. Radiotherapy consisted of 50 GY whole-brain irradiation, with a tumor saturation up to 60 GY. In 2 cases we suspected radiogenic necrosis. There were no other severe side effects. Of the 37 patients, 4 obtained a long-term cure (observation time 34-90 months). Therapy must take all methods of treatment into consideration and should only be carried out in fully equipped medical centers. Only then can we hope to obtain long-term cures in individuals with this usually fatal disease.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 22 条
[1]   PROGNOSTIC FACTORS IN UNSELECTED PATIENTS WITH NONSEMINOMATOUS METASTATIC TESTICULAR CANCER - A MULTICENTER EXPERIENCE [J].
AASS, N ;
KLEPP, O ;
CAVALLINSTAHL, E ;
DAHL, O ;
WICKLUND, H ;
UNSGAARD, B ;
BALDETORP, L ;
AHLSTROM, S ;
FOSSA, SD .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) :818-826
[2]  
ATHANASSIOU A, 1983, CANCER, V52, P1728, DOI 10.1002/1097-0142(19831101)52:9<1728::AID-CNCR2820520929>3.0.CO
[3]  
2-U
[4]   TREATMENT OF NON-SEMINOMATOUS TESTICULAR-TUMOR IN STAGE-I-IIB [J].
CLEMM, C ;
SAUER, H ;
HARTENSTEIN, R .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (34) :1276-1282
[5]  
CLEMM C, 1989, FORTSCHR MED 1, V29, P615
[6]   SANCTUARY SITE RELAPSE IN CHEMOTHERAPY-TREATED TESTICULAR CANCER [J].
JAMES, PPB ;
MEAD, GM .
ANNALS OF ONCOLOGY, 1992, 3 (01) :41-43
[7]   BRAIN METASTASIS FROM NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - CASE-REPORT AND REVIEW OF THE ROLE OF SURGERY [J].
JELSMA, RK ;
CARROLL, M .
NEUROSURGERY, 1989, 25 (05) :814-819
[8]   BRAIN METASTASES IN MALIGNANT TERATOMA - REVIEW OF 4 YEARS EXPERIENCE AND AN ASSESSMENT OF THE ROLE OF TUMOR-MARKERS [J].
KAYE, SB ;
BAGSHAWE, KD ;
MCELWAIN, TJ ;
PECKHAM, MJ .
BRITISH JOURNAL OF CANCER, 1979, 39 (03) :217-223
[9]   COMBINATION CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE FOR MALIGNANT INTRACRANIAL GERM-CELL TUMORS - AN EXPERIMENTAL AND CLINICAL-STUDY [J].
KOBAYASHI, T ;
YOSHIDA, J ;
ISHIYAMA, J ;
NODA, S ;
KITO, A ;
KIDA, Y .
JOURNAL OF NEUROSURGERY, 1989, 70 (05) :676-681
[10]  
LESTER SG, 1984, J CLIN ONCOL, V12, P1397